Press release
Global and United States Axicabtagene Ciloleucel Market Report & Forecast 2022-2028
This report focuses on global and United States Axicabtagene Ciloleucel market, also covers the segmentation data of other regions in regional level and county level.Global Axicabtagene Ciloleucel Scope and Market Size
Axicabtagene Ciloleucel market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Axicabtagene Ciloleucel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Axicabtagene Ciloleucel market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
68 mL
Other
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Kite Pharma
Fosun Kite
Research Objectives
To study and analyze the global Axicabtagene Ciloleucelconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Axicabtagene Ciloleucelmarket by identifying its various subsegments.
Focuses on the key global Axicabtagene Ciloleucelmanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Axicabtagene Ciloleucelwith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Axicabtagene Ciloleucelsubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Study Coverage
1.1 Axicabtagene Ciloleucel Revenue in Axicabtagene Ciloleucel Business (2017-2022) & (US$ Million) Introduction
1.2 Global Axicabtagene Ciloleucel Outlook 2017 VS 2022 VS 2028
1.2.1 Global Axicabtagene Ciloleucel Market Size for the Year 2017-2028
1.2.2 Global Axicabtagene Ciloleucel Market Size for the Year 2017-2028
1.3 Axicabtagene Ciloleucel Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Axicabtagene Ciloleucel in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Axicabtagene Ciloleucel Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Axicabtagene Ciloleucel Market Dynamics
1.4.1 Axicabtagene Ciloleucel Industry Trends
1.4.2 Axicabtagene Ciloleucel Market Drivers
1.4.3 Axicabtagene Ciloleucel Market Challenges
1.4.4 Axicabtagene Ciloleucel Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Axicabtagene Ciloleucel by Type
2.1 Axicabtagene Ciloleucel Market Segment by Type
2.1.1 68 mL
2.1.2 Other
2.2 Global Axicabtagene Ciloleucel Market Size by Type (2017, 2022 & 2028)
2.3 Global Axicabtagene Ciloleucel Market Size by Type (2017-2028)
2.4 United States Axicabtagene Ciloleucel Market Size by Type (2017, 2022 & 2028)
2.5 United States Axicabtagene Ciloleucel Market Size by Type (2017-2028)
3 Axicabtagene Ciloleucel by Application
3.1 Axicabtagene Ciloleucel Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Axicabtagene Ciloleucel Market Size by Application (2017, 2022 & 2028)
3.3 Global Axicabtagene Ciloleucel Market Size by Application (2017-2028)
3.4 United States Axicabtagene Ciloleucel Market Size by Application (2017, 2022 & 2028)
3.5 United States Axicabtagene Ciloleucel Market Size by Application (2017-2028)
4 Global Axicabtagene Ciloleucel Competitor Landscape by Company
4.1 Global Axicabtagene Ciloleucel Market Size by Company
4.1.1 Top Global Axicabtagene Ciloleucel Companies Ranked by Revenue (2021)
4.1.2 Global Axicabtagene Ciloleucel Revenue by Player (2017-2022)
4.2 Global Axicabtagene Ciloleucel Concentration Ratio (CR)
4.2.1 Axicabtagene Ciloleucel Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Axicabtagene Ciloleucel in 2021
4.2.3 Global Axicabtagene Ciloleucel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Axicabtagene Ciloleucel Headquarters, Revenue in Axicabtagene Ciloleucel Business (2017-2022) & (US$ Million) Type
4.3.1 Global Axicabtagene Ciloleucel Headquarters and Area Served
4.3.2 Global Axicabtagene Ciloleucel Companies Revenue in Axicabtagene Ciloleucel Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Axicabtagene Ciloleucel Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Axicabtagene Ciloleucel Market Size by Company
4.5.1 Top Axicabtagene Ciloleucel Players in United States, Ranked by Revenue (2021)
4.5.2 United States Axicabtagene Ciloleucel Revenue by Players (2020, 2021 & 2022)
5 Global Axicabtagene Ciloleucel Market Size by Region
5.1 Global Axicabtagene Ciloleucel Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Axicabtagene Ciloleucel Market Size by Region (2017-2028)
5.2.1 Global Axicabtagene Ciloleucel Market Size by Region: 2017-2022
5.2.2 Global Axicabtagene Ciloleucel Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Axicabtagene Ciloleucel Market Size YoY Growth 2017-2028
6.1.2 North America Axicabtagene Ciloleucel Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Axicabtagene Ciloleucel Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Axicabtagene Ciloleucel Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Axicabtagene Ciloleucel Market Size YoY Growth 2017-2028
6.3.2 Europe Axicabtagene Ciloleucel Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Axicabtagene Ciloleucel Market Size YoY Growth 2017-2028
6.4.2 Latin America Axicabtagene Ciloleucel Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Axicabtagene Ciloleucel Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Axicabtagene Ciloleucel Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Kite Pharma
7.1.1 Kite Pharma Company Details
7.1.2 Kite Pharma Business Overview
7.1.3 Kite Pharma Axicabtagene Ciloleucel Introduction
7.1.4 Kite Pharma Revenue in Axicabtagene Ciloleucel Business (2017-2022)
7.1.5 Kite Pharma Recent Development
7.2 Fosun Kite
7.2.1 Fosun Kite Company Details
7.2.2 Fosun Kite Business Overview
7.2.3 Fosun Kite Axicabtagene Ciloleucel Introduction
7.2.4 Fosun Kite Revenue in Axicabtagene Ciloleucel Business (2017-2022)
7.2.5 Fosun Kite Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
If you would like to get a FREE sample, place an order, or have any questions, please enter
https://us.qyresearch.com/reports/347325/axicabtagene-ciloleucel
Any doubts and questions will be welcome.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
This report focuses on global and United States Axicabtagene Ciloleucel market, also covers the segmentation data of other regions in regional level and county level.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global and United States Axicabtagene Ciloleucel Market Report & Forecast 2022-2028 here
News-ID: 2597097 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Axicabtagene
CAR T-cell Therapy Market to be Worth $51.6 Billion by 2030
Meticulous Research®-a leading market research company, published a research report titled, 'CAR T-cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]), Target Antigen (CD, BCMA, HER2), Indication (Lymphoma, ALL, AML, Multiple Myeloma) - Global Forecast to 2030.'
According to this latest publication from Meticulous Research®, the CAR T-cell therapy market is projected to reach $51.6 billion by 2030, at a CAGR of 43.3% from 2023 to…
CAR T-cell Therapy Market to be Worth $51.6 Billion by 2030
Meticulous Research®-a leading market research company, published a research report titled, 'CAR T-cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]), Target Antigen (CD, BCMA, HER2), Indication (Lymphoma, ALL, AML, Multiple Myeloma)-Global Forecast to 2030.
According to this latest publication from Meticulous Research®, the CAR T-cell therapy market is projected to reach $51.6 billion by 2030, at a CAGR of 43.3% from 2023 to 2030.…
CAR T-cell Therapy Market to be Worth $51.6 Billion by 2030
Meticulous Research®-a leading market research company, published a research report titled, 'CAR T-cell Therapy Market by Brand (Abecma [idecabtagene vicleucel], Breyanzi [lisocabtagene maraleucel], Yescarta [axicabtagene ciloleucel]), Target Antigen (CD, BCMA, HER2), Indication (Lymphoma, ALL, AML, Multiple Myeloma) - Global Forecast to 2030.'
According to this latest publication from Meticulous Research®, the CAR T-cell therapy market is projected to reach $51.6 billion by 2030, at a CAGR of 43.3% from 2023 to…
CAR T-Cell Therapy Market: Requirement for Treatment of Relapsed Large B-Cell Ly …
According to a recent study by Persistence Market Research, the global CAR T-cell therapy market is anticipated to experience high growth over the coming years. The market is expected to grow from US$ 1.2 Bn in 2020 to over US$ 2.8 Bn by 2031, which reflects a CAGR of around 5.6% for the next ten years.
Key players in the CAR T-cell therapy space are focusing on acquisitions and collaborations with…
CAR T-Cell Therapy Market To Upscale Through Digitized Medical Devices, Reaching …
The global CAR T-Cell Therapy Market is expected to witness a CAGR of 5.6% and reach US$ 2.8 Bn by the year 2031. With the way in which healthcare data gets accumulated these days (which could be inclusive of medical IoT solutions, DICOM files, and patient records), ultra-modern platforms like data fabrics are in the offing, so that distributed and structured data could be well-managed. This would be healthcare industry's…
The Car T Cell Therapy Market to continue with its winning cycle based on digiti …
The Car T Cell Therapy Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare…
